KBLB (Kraig Biocraft Laboratories) Long-Term Capital Lease Obligation : $0.04 Mil (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Kraig Biocraft Laboratories Long-Term Capital Lease Obligation?

Kraig Biocraft Laboratories's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.04 Mil.

Kraig Biocraft Laboratories's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 ($0.04 Mil) to Dec. 2024 ($0.04 Mil) and declined from Dec. 2024 ($0.04 Mil) to Mar. 2025 ($0.04 Mil).

Kraig Biocraft Laboratories's annual Long-Term Capital Lease Obligation increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.05 Mil) but then declined from Dec. 2023 ($0.05 Mil) to Dec. 2024 ($0.04 Mil).

Kraig Biocraft Laboratories Long-Term Capital Lease Obligation Historical Data

The historical data trend for Kraig Biocraft Laboratories's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kraig Biocraft Laboratories Long-Term Capital Lease Obligation Chart

Kraig Biocraft Laboratories Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.26

0.06

0.02

0.05

0.04

Kraig Biocraft Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.06	0.05	0.04	0.04	0.04

Kraig Biocraft Laboratories (OTCPK:KBLB) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Kraig Biocraft Laboratories Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kraig Biocraft Laboratories's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kraig Biocraft Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Kraig Biocraft Laboratories Inc (OTCPK:KBLB) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104

Website

https://www.kraiglabs.com

Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra.

Executives

Jonathan Richard Rice	officer: COO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48104
Kimberly Kraig Thompson	director, 10 percent owner, officer: CEO, CFO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48401